does tirzepatide disrupt sleep Frontiers What clinicians should know about

This structural modification allows IGF-1 LR3 to circulate unbound and biologically active for 2030 hours, whereas native IGF-1 remains more than 99% bound to IGFBP-3 with a half-life of only 10 minutes

79 KalebicT.KinterA.PoliG.AndersonM

An international study conducted by Leonard Yeo (National University Hospital, Singapore) and colleagues has found that the presence of atrial fibrillation does not modify the treatment effect of bridging intravenous thrombolysis (IVT) in ischaemic stroke patients undergoing a thrombectomy

Electrolyte depletion sneaks up on people because it happens gradually

Yes, we prescribe Wegovy, Zepbound, Mounjaro, and Ozempic

Immunotherapy in myeloma: how far have we come